Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug
Authors
Keywords
-
Journal
Future Oncology
Volume 9, Issue 5, Pages 633-643
Publisher
Future Medicine Ltd
Online
2013-05-07
DOI
10.2217/fon.13.28
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
- (2012) E.- F. Solomayer et al. ANNALS OF ONCOLOGY
- Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study
- (2012) G. V. Scagliotti et al. ANNALS OF ONCOLOGY
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls
- (2012) Jörg Schilcher et al. BONE
- Seed, soil and secreted hormones: Potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonates
- (2012) C. Wilson et al. CANCER TREATMENT REVIEWS
- Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?
- (2012) P. Hadji et al. CANCER TREATMENT REVIEWS
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial
- (2012) Joanne L Welton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Health in Adult Cancer Survivorship
- (2012) Maryam B. Lustberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis
- (2012) Maria A. Lopez-Olivo et al. SUPPORTIVE CARE IN CANCER
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
- (2011) R. Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Direct antitumour activity of zoledronic acid: preclinical and clinical data
- (2011) Joaquim Bosch-Barrera et al. Clinical & Translational Oncology
- Consensus on the utility of bone markers in the malignant bone disease setting
- (2011) Robert Coleman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Farnesyl pyrophosphate synthase modulators: a patent review (2006 – 2010)
- (2011) Shuting Sun et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases
- (2011) Guilin Wang et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour macrophages as potential targets of bisphosphonates
- (2011) Thea L Rogers et al. Journal of Translational Medicine
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
- (2010) Verena Stresing et al. BONE
- Biochemical and molecular mechanisms of action of bisphosphonates
- (2010) Michael J. Rogers et al. BONE
- Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance
- (2010) Xinmin Zhao et al. BREAST CANCER RESEARCH AND TREATMENT
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro
- (2009) Laura M. Mitrofan et al. BONE
- Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro
- (2009) Johanna Räikkönen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
- (2009) Penelope D. Ottewell et al. INTERNATIONAL JOURNAL OF CANCER
- The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
- (2009) Matthew R. Allen et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Biodistribution and Plasma Protein Binding of Zoledronic Acid
- (2008) H. M. Weiss et al. DRUG METABOLISM AND DISPOSITION
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started